Evidence map›Paper›PMID 35947329›Full record

ArticleThe protein journal2022

Biochemical and Biophysical Characterization of Carbonic Anhydrase VI from Human Milk and Saliva.

Alma Yrjänäinen, Maarit S Patrikainen, Latifeh Azizi, Martti E E Tolvanen, Mikko Laitaoja, Janne Jänis, Vesa P Hytönen, Alessio Nocentini, Claudiu T Supuran, Seppo Parkkila

Open access · hybridAbstract read
In one paragraph

Article in The protein journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Alma YrjänäinenFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Maarit S PatrikainenFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Maarit.Patrikainen@tuni.fi.ORCID 0000-0001-9698-278X
Latifeh AziziFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Martti E E TolvanenDepartment of Computing, University of Turku, Turku, Finland.
Mikko LaitaojaDepartment of Chemistry, University of Eastern Finland, Joensuu, Finland.
Janne JänisDepartment of Chemistry, University of Eastern Finland, Joensuu, Finland.
Vesa P HytönenFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Alessio NocentiniNeurofarba Department, Sezione di Chimica Farmaceutica, University of Florence, Florence, Italy.
Claudiu T SupuranNeurofarba Department, Sezione di Chimica Farmaceutica, University of Florence, Florence, Italy.
Seppo ParkkilaFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Tampere University · FIUniversity of Eastern Finland · FIUniversity of Florence · ITTampere University of Applied Sciences · FIUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbonic anhydrases (CA, EC 4.2.1.1) catalyze the hydration of carbon dioxide and take part in many essential physiological processes. In humans, 15 CAs are characterized, including the only secreted isoenzyme CA VI. CA VI has been linked to specific processes in the mouth, namely bitter taste perception, dental caries, and maintenance of enamel pellicle, and implicated in several immunity-related phenomena. However, little is known of the mechanisms of the above. In this study, we characterized human CA VI purified from saliva and milk with biophysical methods and measured their enzyme activities and acetazolamide inhibition. Size-exclusion chromatography showed peaks of salivary and milk CA VI corresponding to hexameric state or larger at pH 7.5. At pH 5.0 the hexamer peaks dominated. SDS- PAGE of milk CA VI protein treated with a bifunctional crosslinker further confirmed that a majority of CA VI is oligomers of similar sizes in solution. Mass spectrometry experiments confirmed that both of the two putative N-glycosylation sites, Asn67 and Asn256, are heterogeneously glycosylated. The attached glycans in milk CA VI were di- and triantennary complex-type glycans, carrying both a core fucose and 1 to 2 additional fucose units, whereas the glycans in salivary CA VI were smaller, seemingly degraded forms of core fucosylated complex- or hybrid-type glycans. Mass spectrometry also verified the predicted signal peptide cleavage site and the terminal residue, Gln 18, being in pyroglutamate form. Thorough characterization of CA VI paves way to better understanding of the biological function of the protein.

Indexed as

Carbonic AnhydrasesMilk, HumanSalivaFucoseHumansCarbonic Anhydrasescarbonic anhydrase VIFucoseCA6CA VIGlycosylationMass spectrometryOligomerizationSize exclusion chromatography

Identifiers

PMID35947329
PMCPMC9464147
OpenAlexW4295128289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.